More info on San Diego People: Local BioTech Companies
San Diego People: Local BioTech Companies - BingNews Search results
Pharmaceutical industry backs Democratic holdouts on drug pricing plan
The plan would allow Medicare programs to negotiate lower costs for prescription drugs instead of pharmaceutical companies setting their own prices ... staged a protest Friday morning at his San Diego ...
San Diego International Airport: Bouncing back
With traffic on the rise and a host of new domestic routes launched in the last few months, San Diego International Airport’s bounce back from COVID is beginning to gather pace. Sixteen new domestic ...
So-called Dem ‘moderates’ sabotage Medicare power to bargain drug prices
WASHINGTON—Three so-called House Democratic moderates, two of whom have received thousands of dollars in campaign cash from Big Pharma, voted this week to sabotage Medicare’s power to bargain drug ...
San Diego biotech allies warn drug pricing bill stifles cures. Critics don’t buy it.
A bill that would allow Medicare to negotiate drug prices is fueling a fierce debate over how best to make medications affordable.
Why the Memphis Bioworks Foundation decided to end operations after two decades
Memphis’ would-be blockbuster pharmaceutical company that ultimately stumbled and moved to San Diego. It backed and nurtured an array of promising local medical device and bioscience startups ...
RNA revolutionized COVID-19 vaccines; local biotech company is betting that’s just the beginning
Replicate Bioscience emerged from stealth mode this month with an ambitious vision for how RNA treatments can combat cancer, autoimmune disease and inflammatory disorders. It’s a goal that seems more ...
Column: Drugmakers see disaster in Medicare negotiating prices. Don’t listen to them
The pharmaceutical industry, bizarrely, told the American people this week that allowing ... Scott Peters of biotech-heavy San Diego, voted down the price-negotiation proposal Wednesday.
Philip Morris Is Buying An Asthma Inhaler Company. Health Groups Are Suspicious
The purchase "is the latest reprehensible choice from a company that has profited from addicting users to its deadly products," the American Lung Association said.
Could VC Investment Spike In Life Sciences Become Too Much Of A Good Thing?
Rising rents for life sciences spaces and increasing venture capital investment in the sector appear to be correlated.
ARS Pharma Raises $55M
ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an epinephrine nasal spray.
RNA revolutionized COVID vaccines. A new San Diego biotech bets that’s just the beginning
There had been some pretty big failures, and people ... Other companies are already pursuing similar strategies, including San Diego biotech Arcturus Therapeutics and local manufacturer TriLink ...